Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 18, 2025
Arizona Businesses Brace for Monsoon Dust Storms with Emergency Packaging Solutions
EIN Presswire
·
May 18, 2025
Protect your Arizona business from dust storm damage with expert crating, packaging, and rapid-response shipping solutions from Craters …
Celebrating International Museum Day: Museums Turn to Directional Sound for Clearer Storytelling
EIN Presswire
·
May 18, 2025
LOS ANGELES, CA, UNITED STATES, May 18, 2025 /EINPresswire.com/ -- As museums across the globe celebrate International Museum Day, spotlight is being cast on an emerging innovation quietly transforming visitor experiences: directional sound technology. …
Modat’s Feature Finding Series: Cybersecurity Pros Can Use Modat Magnify to Help Make Discoveries
EIN Presswire
·
May 18, 2025
Modat’s Feature Finding Series: Cybersecurity Pros Can Use Modat Magnify to Help Make Discoveries DEN HAAG, NETHERLANDS, May 18, 2025 /EINPresswire.com/ -- Modat, the research-driven, AI-powered cybersecurity company, is proud to share about our ongoing …
Medicines for Poland: L'Europa si trova di fronte a una scelta cruciale sulla riforma del mercato e dei farmaci
GlobeNewswire
·
May 18, 2025
VARSAVIA, Polonia, May 19, 2025 (GLOBE NEWSWIRE) -- Il dibattito tra gli Stati membri in merito alla riforma farmaceutica dell'UE per garantire farmaci a prezzi accessibili e sostenere la produzione europea è quasi giunto al termine. La strategia punta a …
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 18, 2025
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting
GlobeNewswire
·
May 18, 2025
Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …